Acusphere, Inc.

A Phase 3, International, Exploratory, Open-Label, Multicenter, Dual-Injection, Echocardiographic Imaging Settings and Safety Study of AI-700 in Normal Volunteers and Stable Cardiac Patients (Acquiring Consensus for Contrast Echocardiography System Settings - ACCESS Study) - ACCESS